Skip to content

A study of bone regeneration for maxillofacial bone defect patient using autologous iliac bone marrow stem cells

A study of bone regeneration for maxillofacial bone defect patient using autologous iliac bone marrow stem cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015644
Enrollment
Unknown
Registered
2018-04-12
Start date
2015-11-20
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillofacial bone defect

Interventions

control group:Guided bone regeneration technique
Stem Cell transplantation group:autologous iliac bone marrow mensenchymal stem cell transplant

Sponsors

Nanjing Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Maxillofacial bone defect patients between 16 to 60 years old, without gender limit; 2. The maxillofacial bone defect should be caused by severe periodontitis, cleft lip and palate or alveolar cleft; 3. No systemic disease; 4. No unhealthy living habit; 5. The patients must be informed and agreed with this experiment with signing Informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patient has participated in other clinical experiment in four weeks before the initiation of our experiment; 2. Using or once long term used bisphosphonates; 3. Using aspirin in nearly 5 days; 4. Pregnant or lactating women; 5. Failed to meet the age requirement; 6. Systemic disease or abnormal renal and liver function.

Design outcomes

Primary

MeasureTime frame
Bone mass and bone mineral density;esthetic and function of soft and hard tissue(white-and-pink esthetic);Long term successful rate;

Countries

China

Contacts

Public ContactHaiyan Qin

Nanjing Stomatological Hospital

haiyanandrew@163.com+86 13611580285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026